Combining advanced therapies: A hope for breaking the glass ceiling in IBD (notice n° 1845661)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01182cam a2200169 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20260329005707.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Roblin, Xavier |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Combining advanced therapies: A hope for breaking the glass ceiling in IBD |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2026.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 31 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Metastatic gastrointestinal cancer is not an uncommon scenario, particularly in pancreatic, gastric, and colorectal cancers. In this context, there is limited data on the impact of treating the primary tumor. Oligometastatic disease is associated with longer survival compared to more advanced stages. Metastasis-directed therapies, such as stereotactic body radiotherapy, appear to be associated with improved outcomes; however, the level of evidence remains low. For most tumor sites, prospective data are very limited, and participation in ongoing clinical trials is strongly recommended. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barrau, Mathilde |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Hépato-Gastro & Oncologie Digestive | 33 | 1 | 2026-02-10 | p. 9-10 | 2115-3310 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://stm.cairn.info/journal-hepato-gastro-oncologie-digestive-2026-1-page-9?lang=en&redirect-ssocas=7080">https://stm.cairn.info/journal-hepato-gastro-oncologie-digestive-2026-1-page-9?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux